...
首页> 外文期刊>Taiwanese journal of obstetrics and gynecology >New primers for methylation-specific polymerase chain reaction enhance specificity of detecting STAT1 methylation
【24h】

New primers for methylation-specific polymerase chain reaction enhance specificity of detecting STAT1 methylation

机译:用于甲基化特异性聚合酶链反应的新引物增强了检测STAT1甲基化的特异性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: Signal transducer and activator of transcription (STAT)1 is a key tumor suppressor, which is always methylated in a variety of human cancers. However, nonspecific primers for the detection of specific promoter hypermethylation of STAT1 gene can lead to false-positive or false-negative results for gene methylation. Materials and Methods: We designed new primers for the detection of STAT1 methylation and compared the sensitivities and specificities of these new primers with prior published primers by methylation-specific polymerase chain reaction (PCR) from ovarian clear cell carcinomas. The mRNA expression levels of STAT1 in these cancerous tissues were also evaluated by reverse-transcriptase PCR and correlated with the results of promoter methylation of STAT1 gene. Results: Nine (39%) of the 23 samples detected by the new primers and 13 samples (56%) detected by prior published primers showed STAT1 methylation. A direct DNA sequencing test revealed that four of the 13 samples (30.8%) showed false positivity for STAT1 methylation using the prior published primers. In contrast, none of the nine samples was false-positive for the detection of STAT1 methylation using the new primers. The new primers for the detection of STAT1 methylation showed 100% specificity and 100% sensitivity without false positivity. Conclusion: Specific primers for methylation-specific PCR are mandatory for the accurate detection of STAT1 gene methylation. Besides, specific primers can generate correct interpretation of STAT1 gene methylation, and its correlation with the clinicopathological characteristics and outcome of cancer patients.
机译:目的:信号转导子和转录激活子(STAT)1是关键的肿瘤抑制因子,在各种人类癌症中总是甲基化。但是,用于检测STAT1基因特异性启动子高甲基化的非特异性引物会导致基因甲基化的假阳性或假阴性结果。材料和方法:我们设计了用于检测STAT1甲基化的新引物,并通过来自卵巢透明细胞癌的甲基化特异性聚合酶链反应(PCR),将这些新引物的敏感性和特异性与先前发表的引物进行了比较。还通过逆转录酶PCR评估了这些癌组织中STAT1的mRNA表达水平,并与STAT1基因的启动子甲基化结果相关。结果:新引物检测到的23个样品中有9个(39%),以前发表的引物检测到的13个样品(56%)显示STAT1甲基化。直接DNA测序测试显示,使用先前发表的引物,在13个样品中的四个(30.8%)显示出STAT1甲基化的假阳性。相比之下,使用新引物检测STAT1甲基化的9个样品中没有一个是假阳性。用于检测STAT1甲基化的新引物显示出100%的特异性和100%的灵敏度,而没有假阳性。结论:甲基化特异性PCR的特异性引物对于准确检测STAT1基因甲基化必不可少。此外,特异性引物可以正确解释STAT1基因的甲基化及其与癌症患者的临床病理特征和预后的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号